We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
story of the week

Journal Scan / Research · July 30, 2020

Immune Checkpoint Inhibitors for the First-Line Treatment of Patients With Sarcomatoid Renal Cell Carcinoma

European Journal of Cancer


Additional Info

European Journal of Cancer
Patients With Sarcomatoid Renal Cell Carcinoma – Re-Defining the First-Line of Treatment: A Meta-Analysis of Randomised Clinical Trials With Immune Checkpoint Inhibitors
Eur. J. Cancer 2020 Jul 23;136(xx)195-203, R Iacovelli, C Ciccarese, E Bria, S Bracarda, C Porta, G Procopio, G Tortora

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Renal Cell Carcinoma Center of Excellence

Visit our Renal Cell Carcinoma Center of Excellence for additional, in-depth coverage.

Further Reading